INFARMA reports

The impact of the Act on reimbursement of medicines on patient access to medication, the budget of the National Health Fund and the pharmaceutical industry. Regulatory Impact Assessment.

The impact of the Act on reimbursement of medicines on patient access to medication, the budget of the National Health Fund and the pharmaceutical industry. Regulatory Impact Assessment.

Indirect costs in health technology assessment. Methodology, a pilot study and recommendations

Indirect costs in health technology assessment. Methodology, a pilot study and recommendations

Risk-sharing instruments in the drug reimbursement system in Poland and the world

Risk-sharing instruments in the drug reimbursement system in Poland and the world

Clinical Trials in Poland – Key Challenges

Clinical Trials in Poland – Key Challenges

Other reports

The Pharmaceutical Industry in Figures. Key Data 2015.

The Pharmaceutical Industry in Figures. Key Data 2015.

2025 © Copyright: Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA
All Rights Reserved. Wszelkie prawa zastrzeżone.
Made by Raz Dwa Projekt
page: 0,0664 s, time: 0,0759 s cache, query: 36, querytime: 0,0096 s